Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 08, 2022

SELL
$75.79 - $100.07 $6,745 - $8,906
-89 Closed
0 $0
Q1 2022

Apr 12, 2022

SELL
$72.45 - $94.81 $330,879 - $432,997
-4,567 Reduced 98.09%
89 $8,000
Q4 2021

Jan 18, 2022

BUY
$79.65 - $106.22 $370,850 - $494,560
4,656 New
4,656 $397,000
Q1 2021

Apr 09, 2021

SELL
$87.57 - $119.4 $66,378 - $90,505
-758 Closed
0 $0
Q4 2020

Jan 11, 2021

SELL
$86.91 - $108.33 $201,457 - $251,108
-2,318 Reduced 75.36%
758 $73,000
Q3 2020

Oct 23, 2020

BUY
$96.16 - $135.15 $295,788 - $415,721
3,076 New
3,076 $296,000

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $14.5B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Nu Wave Investment Management, LLC Portfolio

Follow Nu Wave Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nu Wave Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nu Wave Investment Management, LLC with notifications on news.